Nexrutine® preserves muscle mass similar to exercise in prostate cancer mouse model

Nexrutine® preserves muscle mass similar to exercise in prostate cancer mouse model

Abstract Muscle loss is a debilitating side effect to prostate cancer (PCa) experienced by nearly 60% of men. The purpose of this study was to test the hypothesis that Nexrutine®, a bark extract from the Phellodendrum amurense, can protect against prostate cancer induced muscle loss in a similar man...

Full description

Bibliographic Details
Main Authors: Darpan I. Patel, Derek Wallace, Kira Abuchowski, Paul Rivas, Amber Gallegos, Nicolas Musi, Addanki Pratap. Kumar
Format: Article
Language:English
Published: Wiley 2019-08-01
Series:Physiological Reports
Subjects:
atrophy
inflammation
natural product
neoplasm of the prostate
proteolysis‐inducing factor
Online Access:https://doi.org/10.14814/phy2.14217

Internet

https://doi.org/10.14814/phy2.14217

Similar Items